Stelexis Therapeutics
Lynn Biderman is an experienced professional who has held various scientific roles in different organizations. Currently, Lynn is working at Stelexis Therapeutics as Associate Director. Previously, Lynn has worked at companies such as Inzen Therapeutics and BioBus, where Lynn served as a Scientist and Volunteer Science Outreach Educator, respectively. Lynn's educational background includes a PhD in Biological Sciences from Columbia University, a Visiting Studentship in Molecular Biology from the Weizmann Institute of Science, and a Bachelor of Arts in Natural Sciences (Biochemistry) from the University of Cambridge.
Stelexis Therapeutics
Stelexis is a Deerfield founded and solely funded New York-based cancer therapeutics company with a mission of transforming cancer therapeutics paradigm and patient care, through the discovery and development of novel drugs.